APELLIS PHARMACEUTICALS INC's ticker is APLS and the CUSIP is 03753U106. A total of 100 filers reported holding APELLIS PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is 1.00 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $430,000 | -21.7% | 6,800 | -46.9% | 0.02% | -25.0% |
| Q1 2021 | $549,000 | -31.5% | 12,800 | -8.6% | 0.02% | -45.9% |
| Q4 2020 | $801,000 | +57.1% | 14,000 | -17.2% | 0.04% | +42.3% |
| Q3 2020 | $510,000 | -7.6% | 16,900 | 0.0% | 0.03% | -16.1% |
| Q2 2020 | $552,000 | +73.0% | 16,900 | +42.0% | 0.03% | +34.8% |
| Q1 2020 | $319,000 | -5.3% | 11,900 | +8.2% | 0.02% | +21.1% |
| Q4 2019 | $337,000 | -6.6% | 11,000 | -26.7% | 0.02% | -13.6% |
| Q3 2019 | $361,000 | -5.0% | 15,000 | 0.0% | 0.02% | -4.3% |
| Q2 2019 | $380,000 | +49.6% | 15,000 | +15.4% | 0.02% | +43.8% |
| Q1 2019 | $254,000 | – | 13,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Octagon Capital Advisors LP | 2,503,059 | $170,959,000 | 29.50% |
| ACUTA CAPITAL PARTNERS, LLC | 554,000 | $37,838,000 | 16.29% |
| Avoro Capital Advisors LLC | 10,125,000 | $691,538,000 | 12.78% |
| Sio Capital Management, LLC | 507,700 | $34,676,000 | 11.02% |
| Logos Global Management LP | 1,300,000 | $88,790,000 | 10.92% |
| EcoR1 Capital, LLC | 5,183,431 | $354,028,000 | 10.45% |
| Cormorant Asset Management, LP | 1,478,000 | $100,947,000 | 7.06% |
| Finepoint Capital LP | 266,090 | $18,174,000 | 5.98% |
| Ghost Tree Capital, LLC | 275,000 | $18,783,000 | 5.27% |
| Boxer Capital, LLC | 1,303,700 | $89,043,000 | 5.01% |